Request Demo
Moleac Names PT Ferron Par Pharmaceuticals as Exclusive Indonesia Partner
1 November 2024
SINGAPORE, Oct. 21, 2024 — Moleac is proud to announce a significant advancement in the journey of NeuroAiD II MLC901 as PT Ferron Par Pharmaceuticals will become our exclusive partner in Indonesia starting January 1st, 2025. Over the past 12 years, our collaboration with PT Mersifarma Tirmaku Mercusana has been highly fruitful, and we extend our deep gratitude to them for their invaluable contributions to our success in Indonesia. As we move forward, we are delighted to welcome PT Ferron Par Pharmaceuticals, a member of Dexa Group, as our new exclusive commercial partner.
This partnership represents a pivotal moment in our mission to broaden access to our innovative products, assisting healthcare professionals in improving outcomes for patients recovering from strokes, traumatic brain injuries, and neurodegenerative diseases. PT Ferron Par Pharmaceuticals, known for its market expertise and operational excellence, will significantly contribute to our accelerated growth and the increased availability of NeuroAiD II MLC901 to those in need.
We anticipate a future marked by growth and continued innovation as we extend the reach of NeuroAiD II MLC901 in Indonesia, benefitting more patients and their families.
About Moleac
Moleac is a biopharmaceutical company committed to helping patients and their families reconnect with their lives. We address the unmet needs of patients suffering from brain function loss due to brain injuries or neurodegenerative diseases. Our goal is to help them regain and maintain their independence. We identify scientifically proven natural compounds and formulations with roots in traditional medicine, establish their clinical properties, and make them available globally.
About PT Ferron Par Pharmaceuticals
PT Ferron Par Pharmaceuticals, part of the Dexa Group, is a rapidly growing pharmaceutical company that began its operations in 2001. Ferron has emerged as one of the 20 largest pharmaceutical entities in Indonesia. With a diverse product portfolio, advanced manufacturing capabilities, and strong partnerships, Ferron continues to enhance its market presence and operational excellence.
This partnership represents a pivotal moment in our mission to broaden access to our innovative products, assisting healthcare professionals in improving outcomes for patients recovering from strokes, traumatic brain injuries, and neurodegenerative diseases. PT Ferron Par Pharmaceuticals, known for its market expertise and operational excellence, will significantly contribute to our accelerated growth and the increased availability of NeuroAiD II MLC901 to those in need.
We anticipate a future marked by growth and continued innovation as we extend the reach of NeuroAiD II MLC901 in Indonesia, benefitting more patients and their families.
About Moleac
Moleac is a biopharmaceutical company committed to helping patients and their families reconnect with their lives. We address the unmet needs of patients suffering from brain function loss due to brain injuries or neurodegenerative diseases. Our goal is to help them regain and maintain their independence. We identify scientifically proven natural compounds and formulations with roots in traditional medicine, establish their clinical properties, and make them available globally.
About PT Ferron Par Pharmaceuticals
PT Ferron Par Pharmaceuticals, part of the Dexa Group, is a rapidly growing pharmaceutical company that began its operations in 2001. Ferron has emerged as one of the 20 largest pharmaceutical entities in Indonesia. With a diverse product portfolio, advanced manufacturing capabilities, and strong partnerships, Ferron continues to enhance its market presence and operational excellence.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.